This Week in Hearing

The ability of human cochlear hair cells to regenerate has been nothing more than a pipe dream – until recently. Frequency Therapeutics, a publicly traded (NASDAQ) company based in Lexington, Massachusetts, has published a series of clinical trials showing early promise that a pharmacologic agent, FX-322, regenerates human hair cells in the cochlea. During this interview with Brian Taylor, Frequency’s

This Week in Hearing co-host, Bob Traynor, is joined by special guest, Dr. Gus Mueller, to celebrate 50 years since his first hearing aid fitting as an audiologist in the US Army stationed at Walter Reed Hospital in Washington, D.C. The pair reflect on how the methods and techniques used to fit hearing aids 50 years ago have changed and

This week, host Dave Kemp is joined by Giles Tongue, CEO of Chatable, and Karl Strom, Editor-In-Chief of The Hearing Review, to discuss their recent experience at the Consumer Electronics Show (CES) in Las Vegas, where a number of audio and hearing-related technologies were on display. They discuss the implications of the latest trends and key takeaways for the hearing

Nearly four out of 10 people Americans will suffer from vertigo at some point in their lives. The sensation that vertigo causes – that you or your environment are moving or spinning can be debilitating and disrupt everyday life – causing people to suffer from dangerous falls, hearing loss, excruciating migraines, and miss work and personal activities. In a breakthrough

Recent research conducted by this week’s guest, Diana Emanuel, PhD of Towson University, suggests that an astounding 60% of audiologists find their way into the profession via the “undergraduate-stumble pathway.” That is, they find audiology through a circuitous route during their first few years of college, typically changing from speech pathology to audiology. Professor Emanuel discusses how this in-direct career

In this week’s episode, Dave Kemp chats with Kat Penno, Director of Hearing Health at Nuheara, and Andy Bellavia, Director of Market Development for Knowles Corp. The 2-part episode provides a deep dive into where things are headed in 2022, including: The increasing sophistication of patient expectations and education Hearing device technology innovations currently underway The evolution of hearing care

Signia, and its predecessor Siemens, has an impressive legacy of innovation geared toward enhancing the real-world performance of individuals with hearing loss. In this episode of This Week in Hearing, Bob and Brian recap many of the key milestones in the history of hearing aid technology over the past 75 years. In addition to their conversation, there were some important

Last week, GN Hearing announced the acquisition of New York based Lively – a leading online direct-to-consumer hearing care retailer for approximately $95 million dollars. GN Hearing CEO, Gitte Aabo, returns to This Week in Hearing to discuss the motivation behind the acquisition with Bob Traynor. The pair discuss how the move strengthens GN’s position to better meet the needs

Hearing aids have never been so sophisticated, yet uptake and consistent daily use often lag behind technological innovation. In this episode of This Week in Hearing Bec Bennett, PhD, researcher at the Ear Science Institute in Perth Australia sits down with Brian Taylor to discuss her research on under-reported hearing aid problems and how they can be handled by clinicians.   Be sure

In this week’s technology spotlight, Dr. Bob Traynor speaks with Robert Koch, the President and Founder of hearing healthcare startup, AHead Simulations. Koch’s company has developed and commercialized CARL, a simulator used widely in audiology training programs across the US and Canada. The pair discuss how simulators, like CARL, can help enhance and improve the clinical training process and how